Submission of Outcome of the 32nd Annual General Meeting.

Novelix Pharmaceuticals limited (Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956 (NOVELIX | 536565 | INE314I01036) 30th September, 2026 The Deputy Manager (Department of Corporate Affairs) BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai- 400023 Sub: Proceedings of the 32nd Annual General Meeting (AGM) held on Wednesday 30th September, 2026. Ref: Scrip Code: 536565 Security Id: NOVELIX Dear Sir/ Madam, This is to inform you that the 32nd Annual General Meeting (AGM) of the members of Novelix Pharmaceuticals Limited was held today i.e., Wednesday, 30th September 2026 at 03:00 P.M. (“IST”) through Video Conferencing (“VC”)/ Other Audio-Visual Means (“OAVM”). In this regard, please find enclosed the proceedings as required under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and record. Thanking you. Yours sincerely For Novelix Pharmaceuticals Limited Venkateshwarlu Pulluru (Whole-time director) DIN: 02076871 Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LIMITED) H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com www.novelixpharma.com Novelix Pharmaceuticals limited (Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956 (NOVELIX | 536565 | INE314I01036) SUMMARY OF PROCEEDINGS OF 32nd ANNUAL GENERAL MEETING (“AGM”) OF THE MEMBERS OF NOVELIX PHARMACEUTICALS LIMITED HELD ON WEDNESDAY SEPTEMBER 30, 2026 AT 03:00 P.M. (“IST”) THROUGH VIDEO CONFERENCING (“VC”)/ OTHER AUDIO-VISUAL MEANS (“OAVM”) The Company Secretary of the Company welcomed the shareholders, Directors, Scrutinizer and Auditors at the 32nd Annual General Meeting of the company and explained the guidelines to shareholders for attending the Annual general Meeting through Video Conferencing (“VC”)/ Other Audio-Visual Means (“OAVM”). He further informed that the requisite quorum for the meeting was present. He further informed about the availability of requisite Registers, Documents, Auditor’s Report, Secretarial Audit Report and documents referred in the notice for inspection electronically during the meeting. He Further informed that, those members who participated in the Annual General Meeting through VC / OAVM facility were provided with the facility of e-voting on Central Depository Services (India) Limited (CDSL) e-voting portal during and after the Meeting. The Company secretary informed that Chairman of the Committees were present during the meeting. He further informed that the Company had appointed Mr. Bharat Khaniwal, Practicing Company Secretary as the Scrutinizer for e-voting. Mr. Venkateshwarlu Pulluru Whole Time Director chaired the Annual General Meeting. The Chairman welcomed the Shareholders to the meeting and introduced the Directors present through VC and also the Key Managerial personnel of the Company. Thereafter, Chairman addressed the members with his speech and further, the meeting was called to order. Following Directors of the Company were also present in the AGM through VC/OAVM: Sr. No. Name of Directors Designation 1. Mr. Venkateshwarlu Pulluru Whole Time Director 2. Dr. Lakshman Samala Independent Director 3. Mr. Gnana Prakash Gattu Director 4. Dr. Janardhan Das Kabra Independent Director 5. Ms. Mayuri Baidya Independent Director 6. Miss Sridevi Belide Director MEMBERS' PRESENT: A total of 73 (Seventy-Three) members were present at the meeting through Video Conferencing or other audio-visual means. The Chairman updated the operational and financial activities of the Company for the financial year 2025-26. With the consent of the Members, the Notice of the Meeting and Auditor's Report were taken as read. Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LIMITED) H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com www.novelixpharma.com Novelix Pharmaceuticals limited (Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956 (NOVELIX | 536565 | INE314I01036) The following business were placed by the Chairman and transacted at the 32nd AGM. SI. No. Details of the Agenda Resolution Mode of Voting (Ordinary /Special) Ordinary Business 1. Item No.1: To receive, consider and adopt: The standalone financial statements of the Company which includes the Audited Balance Sheet as at March 31, 2026, the Statement of Profit and Loss for the financial year Ordinary Resolution E-Voting ended as on that date and the Cash Flow Statement together with reports of the Board of Directors and the Statutory Auditors thereon. 2. Item No.2: To appoint a director in place of Ms. Sridevi Belide (DIN: 10455373), Non-Executive Ordinary Resolution E-Voting Director, who retires by rotation, and being eligible, has offered herself for re-appointment. Special Business: 3. Appointment of Mr. Gnana Prakash Gattu (DIN: 00517921) as Whole Special Resolution E-Voting Time Director of the company: The Chairman invited the queries from the shareholders. The questions raised by the members who have registered as Speaker Shareholders and the queries received during the meeting from the other shareholders were answered appropriately. The Chairman thanked all the Shareholders present in the meeting for their continued support and for attending the Annual General Meeting. The Company Secretary informed that, based on the Scrutinizer's Report, the consolidated voting results will be disseminated to the Stock Exchange on which Company's equity shares are listed and will also be made available on the Company's website at www.novelixpharma.com within 48 hours from the conclusion of the Meeting. After all the agenda items were duly taken up, the meeting concluded at 3:42 P.M. (“IST”) with a vote of thanks to the Chair. Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LIMITED) H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com www.novelixpharma.com Novelix Pharmaceuticals limited (Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956 (NOVELIX | 536565 | INE314I01036) This is for your information and records. Thanking you. Yours sincerely For Novelix Pharmaceuticals Limited Venkateshwarlu Pulluru (Whole-time director) DIN: 02076871 Novelix Pharmaceuticals limited (Formerly Known as TRIMURTHI LIMITED) H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com www.novelixpharma.com